Curt Bradshaw Net Worth & Insider Trades
Curt Bradshaw - Chief Scientific Officer, Arrowhead Pharmaceuticals, Inc
What is Curt Bradshaw's Net Worth?
The current estimated net worth of Arrowhead Pharmaceuticals, Inc's Chief Scientific Officer, Curt Bradshaw, is estimated to be about $21.58M . Curt Bradshaw owns about 0 unit of Arrowhead Pharmaceuticals, Inc common stock. Recently at Arrowhead Pharmaceuticals, Inc, Curt Bradshaw has sold an estimated value of $2.16M worth.
What is Curt Bradshaw's Past Insider Trading?
Curt Bradshaw's largest sale order was 31,250 units , worth over $2.16M on November 23, 2020. In total, Curt Bradshaw has made about 1 transaction recently at Arrowhead Pharmaceuticals, Inc. Curt Bradshaw usually trades in November, with the busiest year in 2020.
Curt Bradshaw
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Curt Bradshaw's Salary in 2020?
As Chief Scientific Officer of Arrowhead Pharmaceuticals, Inc, Curt Bradshaw has a total base salary of $338,462 . Curt Bradshaw received compensation valued at about $6,373,206 in 2020 after becoming Chief Scientific Officer. The vast majority of their compensation came in the form of stock awards of $6,021,250 , other compensation of $13,494 .
What is Curt Bradshaw's' Mailing Address?
- Mailing address is 177 E Colorado Blvd Ste 700 Pasadena CA 91105 CA
Arrowhead Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Christopher Anzalone | 2020 | $785,625 | - | $12,686,000 | - | $820,000 | $2,892 | $14,294,517 |
| Christopher Anzalone | 2019 | $674,375 | - | - | - | $1,540,000 | $1,889 | $2,216,264 |
| Christopher Anzalone | 2018 | $643,012 | - | - | - | $975,000 | $1,889 | $1,619,901 |
| Kenneth Myszkowski | 2020 | $463,750 | - | $5,391,550 | - | $213,750 | $12,802 | $6,081,852 |
| Kenneth Myszkowski | 2019 | $422,500 | - | $1,055,700 | - | $251,550 | $11,799 | $1,741,549 |
| Kenneth Myszkowski | 2018 | $384,841 | - | $276,000 | - | $180,000 | $12,177 | $853,018 |
| Javier San Martin | 2020 | $380,769 | $100,000 | $7,225,500 | - | $180,000 | $12,802 | $7,899,071 |
| Javier San Martin | 2019 | - | - | - | - | - | - | - |
| Javier San Martin | 2018 | - | - | - | - | - | - | - |
| James Hassard | 2020 | $302,404 | - | $7,430,000 | - | $170,000 | $15,892 | $7,918,296 |
| James Hassard | 2019 | - | - | - | - | - | - | - |
| James Hassard | 2018 | - | - | - | - | - | - | - |
| Curt Bradshaw | 2020 | $338,462 | - | $6,021,250 | - | - | $13,494 | $6,373,206 |
| Curt Bradshaw | 2019 | - | - | - | - | - | - | - |
| Curt Bradshaw | 2018 | - | - | - | - | - | - | - |
| Bruce D. Given | 2020 | $409,615 | - | $15,857,500 | - | - | $76,693 | $16,343,808 |
| Bruce D. Given | 2019 | $488,750 | - | $2,608,200 | - | $850,000 | $11,799 | $3,958,759 |
| Bruce D. Given | 2018 | $450,362 | - | $644,000 | - | $445,900 | $11,799 | $1,552,061 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/879407/000119312521019640/d76219ddef14a.htm
What are Arrowhead Pharmaceuticals, Inc's Past Insider Trades?
Arrowhead Pharmaceuticals, Inc's most recent insider trade came on March 6, 2023 by Adeoye Olukotun who sold 11,350 units worth $370.58K . In the last 19 years, insiders at Arrowhead Pharmaceuticals, Inc have sold an estimated value of $162.99M and bought an estimated value of $10.45M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are Christopher Anzalone, Chief Executive Officer, Kenneth Myszkowski, Chief Financial Officer, and Charles McKenney, Director .
ARROWHEAD PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||